1,8-Cineole Affects Agonists-Induced Platelet Activation, Thrombus Formation and Haemostasis

• Published in: Cells (Basel, Switzerland) Vol. 10; no. 10; p. 2616
• Main Authors: Alatawi, Kahdr A, Ravishankar, Divyashree, Patra, Pabitra H, Bye, Alexander P, Stainer, Alexander R, Patel, Ketan, Widera, Darius, Vaiyapuri, Sakthivel
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 01.10.2021; MDPI
• Subjects: 1,8-cineole; Agonists; AKT protein; Animals; Antioxidants; Blood clots; Blood platelets; Blood Platelets - drug effects; Calcium (intracellular); Cells, Cultured; Cineole; Collagen; Essential oils; Eucalyptol - pharmacology; Glycoprotein VI; haemostasis; Hemostasis - drug effects; Humans; Inflammation; Mice; Molecular modelling; Oils & fats; Platelet Activation - drug effects; Platelet aggregation; Platelet Aggregation - drug effects; platelet reactivity; platelets; Syk protein; Thrombin; Thrombosis; Thrombosis - drug therapy; thrombosis; haemostasis; collagen; platelet reactivity; 1,8-cineole; platelets; signalling
• ISSN: 2073-4409; 2073-4409
• DOI: 10.3390/cells10102616

1,8-cineole, a monoterpenoid is a major component of eucalyptus oil and has been proven to possess numerous beneficial effects in humans. Notably, 1,8-cineole is the primary active ingredient of a clinically approved drug, Soledum which is being mainly used for the maintenance of sinus and respiratory health. Due to its clinically valuable properties, 1,8-cineole has gained significant scientific interest over the recent years specifically to investigate its anti-inflammatory and antioxidant effects. However, the impact of 1,8-cineole on the modulation of platelet activation, thrombosis and haemostasis was not fully established. Therefore, in this study, we demonstrate the effects of 1,8-cineole on agonists-induced platelet activation, thrombus formation under arterial flow conditions and haemostasis in mice. 1,8-cineole largely inhibits platelet activation stimulated by glycoprotein VI (GPVI) agonists such as collagen and cross-linked collagen-related peptide (CRP-XL), while it displays minimal inhibitory effects on thrombin or ADP-induced platelet aggregation. It inhibited inside-out signalling to integrin αIIbβ3 and outside-in signalling triggered by the same integrin as well as granule secretion and intracellular calcium mobilisation in platelets. 1,8-cineole affected thrombus formation on collagen-coated surface under arterial flow conditions and displayed a minimal effect on haemostasis of mice at a lower concentration of 6.25 µM. Notably, 1,8-cineole was found to be non-toxic to platelets up to 50 µM concentration. The investigation on the molecular mechanisms through which 1,8-cineole inhibits platelet function suggests that this compound affects signalling mediated by various molecules such as AKT, Syk, LAT, and cAMP in platelets. Based on these results, we conclude that 1,8-cineole may act as a potential therapeutic agent to control unwarranted platelet reactivity under various pathophysiological settings.